Ruger (RGR) Q2 2026 earnings review
Strong Top-Line Recovery Achieved, But 'One-Time' Costs Persist
Ruger delivered a decisive Reversing trend in Q2 2026, successfully flipping a severe prior-year loss into a $7.0M GAAP net income. Revenue surged 19% YoY to $158.1M, outperforming broader industry background checks. Management's aggressive restructuring from Q2 2025 is paying off operationally, with average selling prices jumping 10% and gross profit multiplying to $33.7M. However, investors are still waiting for a perfectly clean quarter, as management booked another round of non-operating adjustments related to Beretta Holding and a CFO transition.
🐂 Bull Case
Ruger's estimated sell-through increased 19% YoY, dramatically beating the 5% increase in adjusted NICS background checks. The company is actively taking market share.
Adjusted EBITDA margin expanded from a depressed 4.1% a year ago to a healthy 10.5%. The 10% YoY increase in Average Selling Price (ASP) to $384 highlights returning pricing power.
🐻 Bear Case
Finished goods inventory dropped by 100,100 units YoY. While management labels this 'disciplined,' it suggests production is struggling to keep pace with demand, risking missed future sales.
For the fourth consecutive quarter, Ruger leaned on 'adjusted' metrics. Q2 included $1.2M in Beretta-related fees, preventing a clean read on true underlying net income.
⚖️ Verdict: 🟢
Bullish. Top-line execution is stellar and the new product pipeline is clearly resonating with consumers. Once the Beretta distraction and related legal fees sunset, the underlying operating leverage will become undeniable.
Key Themes
Market Share Gains Accelerating
Ruger's sell-through momentum is Accelerating dramatically. After beating the market by roughly 8 percentage points in Q4 2025 and 1.6 points in Q1 2026, Q2 sell-through outpaced adjusted NICS checks by a massive 14 percentage points (19% vs 5%). This confirms that consumers are actively choosing Ruger platforms over competitors in a rebounding market.
New Product Pipeline Drives Top-Line
Innovation remains the primary growth engine. Products introduced in the last two years—specifically the RXM pistol, Marlin 1894 lever-action rifles, and American Centerfire Rifle Gen II—accounted for $80.9M, or 29% of firearm sales in the first half of 2026. This validates the heavy CapEx investment into manufacturing capabilities.
Pricing Power and Favorable Mix
Average selling price (ASP) surged 10% YoY to $384. This Reversing trend from previous promotional discounting environments directly contributed to the 400 basis point expansion in adjusted gross margin. It signals that consumers are willing to pay premiums for Ruger's newer, high-demand platforms.
Chronic Use of 'One-Time' Adjustments
Management continues to report messy GAAP numbers. Q2 saw another $1.2M in legal and advisory fees to finalize the Beretta Holding agreement, plus unquantified CFO transition costs. Following $7.4M of adjustments in Q1, the gap between GAAP EPS ($0.43) and Adjusted EPS ($0.52) remains a drag on earnings quality. This Reversing trend in cost control needs to stabilize.
Inventory Depletion Indicates Production Strain
Management praised 'disciplined inventory management,' but the data suggests production is struggling to catch up. Finished goods inventories are down 100,100 units YoY, and distributor inventories are down 45,800 units. While this shows strong pull-through, severely depleted channels risk capping Q3 revenue if the factories cannot rapidly replenish stock.
Macroeconomic Sensitivity Remains
While NICS background checks were up 5% in Q2, the firearms industry remains highly sensitive to discretionary income. Management previously noted 'pressure on discretionary income' in Q1. If inflation or a cooling labor market compresses consumer wallets in H2 2026, Ruger's strategy of pushing higher-ASP products could face friction.
Implementation of the 'Ruger Business System'
Ruger formally established the 'Ruger Business System' this quarter. Management touts it as the new operational framework to execute their '2030 strategy'. While it sounds like corporate jargon, if it successfully standardizes operations across the newly acquired Hebron facility and legacy plants, it could lead to sustained operating margin expansion.
Other KPIs
Accelerating significantly from 4.1% in Q2 2025. This margin expansion proves the severe restructuring pain taken in mid-2025 (inventory write-offs and realignments) successfully reset the cost base, allowing top-line growth to flow through to profitability.
Stable and formidable. Despite returning $3.0M via dividends and funding $8.1M in CapEx YTD, the balance sheet remains bulletproof with zero debt. The current ratio stands at a highly liquid 3.3x.
Guidance
Accelerating. With only $8.1M spent in the first six months of 2026, this guidance implies a significant ramp-up of roughly $21.9M in H2 2026. Management notes these funds are earmarked for expanding capacity of high-demand lines and upgrading infrastructure, which will be critical to rebuilding the depleted finished goods inventory.
Key Questions
Inventory Replenishment Timeline
With finished goods down over 100,000 units YoY, how many quarters will it take for production to catch up and fully replenish distributor channels, and will this require elevated overtime costs?
Beretta Relationship Post-Agreement
Now that the Strategic Cooperation Agreement with Beretta Holding is finalized and proxy fights are avoided, what tangible operational or distribution synergies, if any, will result from this partnership?
End of One-Time Adjustments
Investors have seen 'adjusted' EPS significantly outpace GAAP EPS for four straight quarters due to severance, write-offs, and proxy fees. Can management commit to a clean, adjustment-free Q3?